KRT17 and cervical carcinoma: One study (2.6%) used immunofluorescent staining to determine K17 expression in HNSCC [15], and another study (2.6%) used an ELISA assay with spectrometry to quantify circulating K17 in the serum of patients with cervical cancer [34].